SOLICITATION NOTICE
66 -- ACEA Biosciences xCELLigence Real Time Cell Analyzer-DP Bundle
- Notice Date
- 8/24/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334118
— Computer Terminal and Other Computer Peripheral Equipment Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-CSB-DE-2015-216-KEW
- Archive Date
- 9/15/2015
- Point of Contact
- Kyle Wisor, Phone: 3014023670, Rashida Ferebee,
- E-Mail Address
-
Kyle.Wisor@nih.gov, rashida.ferebee@nih.gov
(Kyle.Wisor@nih.gov, rashida.ferebee@nih.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- (1) Action Code: Combined Synopsis/Solicitation (2) Date: August 24th, 2015 (3) Year: 2015 (4) Contracting Office Zip Code: 20892 (5) Classification Code: 6640 (6) Contracting Office Address: 6701 Rockledge Drive Rockledge II Bethesda, MD 20892 (7) Subject/Title: ACEA Biosciences xCELLigence Real Time Cell Analyzer-DP Bundle (8) Proposed Solicitation Number: NHLBI-CSB-DE-2015-216-KEW (9) Closing Response Date: August 31st, 2015 (10) Contact Point: Kyle Wisor, Contract Specialist (11) Contract Award and Solicitation Number: TBD (12) Contract Award Dollar Amount: UKN (13) Contract Line Item Number(s): Line Item 1: xCELLigence RTCA-DP Bundle; Line Item 2: Shipping (14) Contractor Award Date: September 9th, 2015 (15) Contractor Name: TBD (16) Description: The National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR), Oral Pharyngeal Cancer Branch (OPCB) is researching therapies for tumor treatments. A tumor vaccine is the one of the most promising therapies for tumor treatment among multiple methods of immunotherapy. The vaccine would activate the tumor-specific immunity without affecting the normal tissues. However, the tumor immunity induced by the tumor vaccine may undergo a process called tumor editing in the tumor microenvironment, where the tumor cells may escape the effects of the vaccine, resulting in low immunogenicity, especially in solid tumors. The regulatory T cell (Treg, a type of white blood cell) is one of the important mechanisms by which tumor editing occurs, and these cells can suppress the immune system by directly contacting tumor-specific cytotoxic T cells or through producing proteins called cytokines. Therefore, inhibiting the functions of Treg cells during tumor vaccine treatment may be the solution to increasing the efficiency of tumor-specific immunity. The NIDCR OPCB requires an ACEA xCELLigence RTCA-DP Bundle to help the labs tumor assays and other adherent cell experiments. (i) "This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued." (ii) The solicitation number is NHLBI-CSB-DE-2015-216-KEW and the solicitation is issued as a request for quote (RFQ). (iii) The solicitation document, the incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-83 effective 03 AUG 2015. (iv) This is a small business set aside. The associated NAICS code is 334118, Computer Terminal and Other Computer Peripheral Equipment Manufacturing, and the small business size standard is 1000 Employees. The acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13. (v) The Contractor Requirements are listed below: (vi) The Contractor Shall: 1. The contractor shall provide the ACEA Biosciences xCELLigence RTCA (Real-time Cell Analyzer)-DP Bundle, product number 00380601050, Quantity 1. I. Specifications • RTCA DP Plate Station and Analyzer o Electrical input: +6V DC, 5 W max o Electronic switch resistance: 2-5 ohm o Electrical interface: handling three E-Plate® 16 devices or 3 IM-Plate devices o Communications: RS232 serial communications at a band rate of 57600 bits/second o Environment: 15° C to 40° C, relative humidity: 98% max non-condensing o Output test signal: 22mV rms ± (2% +5 mVrms) @ 10, 25 and 50 kHz o Impedance measure accuracy: ± (2% + 1.5 ohm) o Impedance measurement repeatability: 0.5% o Impedance dynamic range: 5 ohm to 2 kohm o Environment: 5° C to 40° C, Relative humidity: 80% max. up to 31° C decreasing linearly to 50% max at 40° C • RTCA DP Software o User friendly GUI (Graphical User Interface) o Flexible experimental protocol setup o Real-time data acquisition o Real-time numeric and graphic data display o Multiple output formats • RTCA DP WorkStation o Laptop computer capable of running RTCA DP Software (vii) Date of Delivery: Ship upon receipt of the order Place of Delivery: National Institute of Health, NIDCR 30 Convent Drive Building 30, Room 310 Bethesda, MD 20892 (viii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition. (ix) The provision at FAR clause 52.212-2, Evaluation - Commercial Items, is applicable. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: Contract award shall be made to the responsible Offeror whose offer, in conforming to this RFQ, provides the overall best value to the Government, technical evaluation factors, and cost considered. The Government's objective is to obtain the highest technical quality considered necessary to achieve the project objectives, with a realistic and reasonable cost. Technical evaluation factors are more important than cost. 1: Technical Criteria (90 points) I. The contractor will be evaluated on the product provided meeting the below specifications: • RTCA DP Plate Station and Analyzer o Electrical input: +6V DC, 5 W max o Electronic switch resistance: 2-5 ohm o Electrical interface: handling three E-Plate® 16 devices or 3 IM-Plate devices o Communications: RS232 serial communications at a band rate of 57600 bits/second o Environment: 15° C to 40° C, relative humidity: 98% max non-condensing o Output test signal: 22mV rms ± (2% +5 mVrms) @ 10, 25 and 50 kHz o Impedance measure accuracy: ± (2% + 1.5 ohm) o Impedance measurement repeatability: 0.5% o Impedance dynamic range: 5 ohm to 2 kohm o Environment: 5° C to 40° C, Relative humidity: 80% max. up to 31° C decreasing linearly to 50% max at 40° C • RTCA DP Software o User friendly GUI (Graphical User Interface) o Flexible experimental protocol setup o Real-time data acquisition o Real-time numeric and graphic data display o Multiple output formats • RTCA DP WorkStation o Laptop computer capable of running RTCA DP Software 2: Price Criteria (10 points) • Price reasonableness: Best Value (x) FAR clause 52.212-3, Offeror Representations and Certifications - Commercial Items, is applicable. An offeror shall complete only paragraphs (b) of this provision if the offeror has completed the annual representations and certificates electronically via http://www.acquisition.gov. If an offeror has not completed the annual representations and certifications electronically at the System for Award Management (SAM) website, the offeror shall complete only paragraphs (c) through (p) of this provision. (xi) FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. (xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items, applies to this acquisition. Including the following clauses and Prohibitions: i. 52.223-18, Encouraging Contractor Policies to Ban Text Messaging while Driving (AUG 2011) ii. 52.225-13, Restrictions on Certain Foreign Purchases iii. 52.244-6, Subcontracts for Commercial Items iv. 52.2232-39, Unenforceability of Unauthorized Obligations v. 52.219-6, Notice of Total Small Business Set-Aside vi. 52.222-3, Convict Labor vii. 52.222-19, Child Labor--Cooperation with Authorities and Remedies viii. 52.222-26, Equal Opportunity ix. 52.222-35, Equal Opportunity for Veterans x. 52.222-36, Equal Opportunity for Workers with Disabilities xi. 52.222-37, Employment Reports on Veterans xii. 52.222-50 Combating Trafficking in Persons xiii. 52.232-33, Payment by Electronic Funds Transfer-System for Award Management xiv. 52.222-21, Prohibition of Segregated Facilities (xiii) Additional Contract Requirements: None (xiv) The Defense Priorities and Allocations System (DPAS) and assigned rating are not applicable. (xv) All responses must be received by August 31st, 2015 at 9:00 AM and must reference number NHLBI-CSB-DE-2015-216-KEW. Responses may be submitted electronically to Kyle.Wisor@nih.gov or by U.S. mail to the National Heart, Lung, and Blood Institute, Office of Acquisitions, COAC Services Branch, 6701 Rockledge Drive, Suite 6150B, Bethesda, MD 20892-7902, Attention: Kyle Wisor. Phone: 301-402-3670; Fax responses will not be accepted
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/NHLBI-CSB-DE-2015-216-KEW/listing.html)
- Place of Performance
- Address: National Institute of Health, NIDCR, 30 Convent Drive, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN03852507-W 20150826/150824235526-b706abd717e27c5a7eab5b70ac6a029f (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |